ImmunGene
Thousand Oaks, California, United States
About ImmunGene
ImmunGene is a privately held biotechnology company focused on the development of proprietary antibody-cytokine fusion technology and monoclonal antibody-based therapies to treat cancer, autoimmune disorders, and other diseases. ImmunGene has several programs at various stages of development. ImmunGene is funded by federal government grants including the NIH-SBIR and by private investors including several biotechnology executives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2013)
- Website: immungene.com
- Phone: 8054966700
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immungene-2537838 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.